Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-023916

Chief Operating Officer sold 831 shares at $13.17 ($10,944)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2022-04-07 Sale −831 $13.17 $10,944 122,893 D
Open-market sales · 831 sh · avg $13.17 · $10,944
Loading xslF345X03/doc4.xml…